Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 1.32B | 1.00B | 764.04M | 937.82M | 531.51M |
Gross Profit | 597.97M | 475.36M | 297.24M | 667.10M | 364.12M |
EBITDA | 89.48M | 29.91M | -320.65M | 204.26M | 139.92M |
Net Income | -34.13M | -58.54M | -297.50M | 124.86M | 79.48M |
Balance Sheet | |||||
Total Assets | 1.19B | 1.22B | 1.29B | 1.43B | 1.07B |
Cash, Cash Equivalents and Short-Term Investments | 42.69M | 83.16M | 141.00M | 286.45M | 321.06M |
Total Debt | 713.92M | 731.58M | 744.80M | 502.72M | 311.81M |
Total Liabilities | 877.11M | 872.28M | 898.95M | 758.98M | 528.10M |
Stockholders Equity | 316.80M | 346.97M | 391.11M | 674.89M | 545.69M |
Cash Flow | |||||
Free Cash Flow | 3.57M | -28.50M | -372.96M | -138.43M | -77.33M |
Operating Cash Flow | 15.24M | -19.38M | -338.31M | -115.44M | -61.78M |
Investing Cash Flow | -14.85M | -9.13M | -42.58M | -64.02M | -51.37M |
Financing Cash Flow | -40.86M | -29.34M | 235.43M | 97.04M | 481.45M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
63 Neutral | €13.46B | 9.53 | 5.49% | 3.96% | 13.93% | 9.46% | |
58 Neutral | $300.54M | ― | 0.82% | ― | 20.41% | 93.09% | |
51 Neutral | $23.67M | 11.44 | -3.92% | ― | 0.48% | -127.19% | |
51 Neutral | $65.69M | ― | -13.38% | ― | 13.18% | 97.01% | |
47 Neutral | $144.35M | ― | 4.45% | ― | 16.19% | 89.75% | |
45 Neutral | $4.35M | ― | -223.86% | ― | 1.07% | 96.67% | |
41 Neutral | $115.70M | ― | -12.03% | ― | 158.74% | 14.86% |
On July 25, 2025, SelectQuote, Inc. amended its Credit Agreement with Ares Capital Corporation and UMB Bank, extending the revolving facility termination date to September 30, 2027. This amendment, which includes a fee for lenders, impacts the company’s financial operations by providing extended credit flexibility.
The most recent analyst rating on (SLQT) stock is a Hold with a $2.75 price target. To see the full list of analyst forecasts on SelectQuote stock, see the SLQT Stock Forecast page.
On July 1, 2025, SelectQuote announced the passing of William T. Grant II, Vice Chairman and former President, who played a crucial role in the company’s evolution into a diversified insurance and healthcare services business. His leadership significantly impacted the company’s success and the lives of its associates. His sons, Bill and Bob Grant, will continue in their executive roles at SelectQuote.
The most recent analyst rating on (SLQT) stock is a Hold with a $2.75 price target. To see the full list of analyst forecasts on SelectQuote stock, see the SLQT Stock Forecast page.